Abstract
6-GINGEROL FOR CANCER THERAPY- AN IN SILICO APPROACH
Manikesh Kumar*, Priyanka James, M. R. Shylaja and P. A. Nazeem
ABSTRACT
The natural polyphenolic alkanone 6-gingerol, a major pharmacologically active component of ginger has anti-inflammatory and antitumoral properties. Its potent anti-tumor activity has been reported in a variety of cancer types, including breast, pancreatic, gastric, colon and colorectal cancer and certain hematological malignancies. In a cellular milieu, binding of 6-gingerol with a protein could suppress the cancer cell growth and affect the dynamics of protein-protein interaction thereby altering the structure and function of the protein. In the present study, we identified the potential binding proteins of 6- gingerol for various types of cancer. 6-gingerol was docked to targets – epidermal growth factor receptor (EGFR), oestrogen receptor (ER), Cyclooxygenases (COX-2), Cyclin-dependent kinases (CDKs), and p90 ribosomal protein kinase 2 (RSK2) with the Docking software Discovery studio and docking based virtual screening was attempted.
[Full Text Article] [Download Certificate]WJPLS CITATION
All | Since 2019 | |
Citation | 422 | 322 |
h-index | 9 | 7 |
i10-index | 4 | 2 |
INDEXING
NEWS & UPDATION
BEST ARTICLE AWARDS
World Journal of Pharmaceutical and life sciences is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Article of current issue
Download Article : Click here